AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sputnik V Vaccine

Prescription Icon
Prescription Required

Marketer

Dr Reddy's Laboratories Ltd

Salt Composition

Human adenovirus vector vaccine (NA)

Overview Sputnik V Vaccine

Developed by Moscow's Gamaleya Center, Sputnik V is a COVID-19 vaccine authorized for individuals aged 18 and above. Functioning similarly to Covishield, its efficacy exceeds 90% against SARS-CoV-2, and it was the first foreign vaccine approved for emergency use in India. Globally, it holds the distinction of being the first registered COVID-19 vaccine, with approvals in over 60 countries. Manufactured in India by Dr. Reddy's Laboratories and other partners alongside imports, Sputnik V is administered intramuscularly by a healthcare provider in two distinct doses, 21 days apart. This unique two-vector design enhances the immune response, offering broader and longer-lasting protection. Common, mild side effects may include injection site soreness, fatigue, and fever; consult your doctor if these intensify or persist. For your safety, always inform your doctor of any pre-existing health conditions or medications you are currently using.

Primary Ingredients of Sputnik V Vaccine

No text provided. Please provide the text you wish me to rephrase.

Uses of Sputnik V Vaccine

Averting Coronavirus Disease 2019 (COVID-19)

Major Benefits of Sputnik V Vaccine:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Sputnik V Vaccine:

  • Injection site pain
  • Tiredness
  • Fever

How to use Sputnik V Vaccine:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Sputnik V Vaccine works:

The COVID-19 illness is initiated by the SARS-CoV-2 virus, which employs spike proteins to invade human cells. The Sputnik V vaccine utilizes two distinct adenoviral vectors, rAd26 and rAd5, administered in a two-dose regimen. Each vector carries a modified gene encoding the SARS-CoV-2 spike protein, rendered incapable of causing infection. Consequently, vaccination stimulates antibody production, enhancing the body's defense against subsequent viral exposure. This reduces the likelihood of contracting COVID-19 and its associated complications. The utilization of different vectors in each dose strengthens the immune response compared to a homologous approach, potentially providing more durable immunity.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Sputnik V vaccination with alcohol consumption. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Sputnik V vaccination in pregnant individuals is currently unavailable. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Sputnik V vaccine use while breastfeeding is currently unavailable. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The impact of Sputnik V Vaccine on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Sputnik V vaccination in individuals with kidney conditions is scarce. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Sputnik V Vaccine use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Sputnik V Vaccine :

NA

Facts to Know About Sputnik V Vaccine

LabelValue
Developing Habits No.
Treatment Category Immunizations

FAQs on Sputnik V Vaccine

Among the world's vaccines, Sputnik V boasts over 90% reported efficacy. The Lancet's published clinical trial data indicates an absence of serious adverse events, with mild side effects—primarily flu-like symptoms, injection site reactions, headache, and fatigue—predominating.
Currently, the Sputnik V vaccine's safety and efficacy haven't been evaluated in children. Current guidelines restrict its use to individuals 18 and older. Consequently, administering any COVID-19 vaccine to children is not recommended until sufficient data becomes available.
Sputnik V's effectiveness hinges on receiving both doses. Each dose contains a different weakened adenovirus (rAd26 and rAd5), designed to trigger a stronger, longer-lasting immune response. These common cold viruses are well-studied, and clinical trials showed significantly improved immunity with both doses administered 21 days apart. Therefore, completing the two-dose regimen is crucial for optimal protection.
Sputnik V vaccination may cause injection site pain, fatigue, and fever, typically mild and temporary. Persistent or bothersome symptoms warrant a doctor's consultation for appropriate management.
Sputnik V's storage requirements, in accordance with Russian regulations, are 2°C to 8°C, facilitating global distribution.
Among the three vaccines globally boasting over 90% efficacy—Pfizer-BioNTech and Moderna being the others—Sputnik V achieved a 91.6% efficacy rate. This figure resulted from analyzing data collected from more than 19,800 participants who received both doses.
Globally, at least 14 vaccines have received approval. Prominent examples beyond Sputnik V include Pfizer-BioNTech, Oxford/AstraZeneca, Moderna, Janssen (Johnson & Johnson), Covaxin, and Covishield. Janssen, AstraZeneca, Covishield, and Sputnik utilize non-replicating viral vector technology; Moderna and Pfizer-BioNTech employ RNA technology; and Covaxin uses an inactivated protein subunit. All aim to prevent COVID-19, with ongoing research and development continuing. Most vaccines require two doses; however, Janssen is a single-dose vaccine.
Yes. COVID-19 vaccination is recommended for those with prior infection, unless a healthcare provider advises against it. Vaccination provides an immune boost even after prior infection, reducing the risk of reinfection, a known possibility.
Yes. Current vaccines offer significant protection against emerging COVID-19 variants. They stimulate the production of diverse antibodies, effectively neutralizing the virus. Available data suggests these mutations are unlikely to render the vaccines ineffective, providing continued protection against COVID-19.
Indian regulators grant Emergency Use Authorization (EUA) for vaccines, medicines, or diagnostic devices to combat serious public health threats like COVID-19. This authorization, mirroring international practices, permits restricted use even without full regulatory approval, balancing potential benefits against risks. Ongoing laboratory assessments and clinical trials continuously monitor safety, efficacy, and quality.
COVID-19, or coronavirus disease 2019, is a new lung illness caused by the SARS-CoV-2 virus. This highly contagious virus spreads rapidly between people. Common symptoms include fever, cough, and shortness of breath.
Sputnik V Vaccine
1